News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GW Medical Technologies, LLC Announces Study Team For Its Phase II Alzheimer's Blood Diagnostic Test



11/14/2006 3:43:24 PM

PHOENIX--(BUSINESS WIRE)--GW Medical Technologies LLC was recently awarded a $1,036,000 Phase II SBIR Grant from the National Institute on Aging, a division of the National Institutes of Health. The grant will assist GW Medical to further develop, refine and commercialize its new LymPro Test®, a blood diagnostic test for early detection of Alzheimer’s disease (AD).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES